L’UTOG est à l’origine et impliquée dans plusieurs protocoles de recherche pour les sujets âgés atteints de cancer: PREDOMOS, ONCO-EHPAD, CHIMIOAGE, CELL, GERICO 14.

Les articles récents sont:
AL Couderc, E Nouguerède, K Baumstarck, S Loubière, H Le Caer, O Guillem, F Rousseau, L Greillier, E Norguet, M Cecile, R Boulahssass, F Le Caer, S Tournier, C Butaud, P Guillet , S Nahon, S Kirscher, N Diaz, C Morando, P Villani, P Auquier, A Daumas. PREDOMOS study, Impact of a social intervention program for socially isolated elderly cancer patients: Update to the study protocol for a randomized controlled Trial. Update. Trials 2019 ;20:54.
AL Couderc, R Boulahssass, E Nouguerède, N Gobin, O Guérin, P Villani, F Barlesi, E Paillaud. Functional status in a geriatric oncology setting. Journal of Geriatric Oncology 2019 (in press). https://doi.org/10.1016/j.jgo.2019.02.004

Lien avec le site internet du réseau ONCOPACA Corse : http://www.oncopaca.org/fr/cancer-sujets-ages

Filières :

• FIRENDO : Filière Maladies Rares ENDOcrinennes
• ORKID : Filière maladies rénales rares (OR KIdney Disease)
• OSCAR : Filière maladies rares de l'os, du calcium et du cartilage

Réseaux :

• Réseau National d’oncogénétique des tumeurs endocrines. TENGEN Coordonnateur Pr Anne BARLIER, Laboratoire de Biologie Moléculaire Hôpital de la Conception, CHU Marseille.
• Réseau ANPGM des laboratoire de génétique moléculaire des Maladies rares Endocriniennes, coordonnateur Pr Anne BARLIER, Laboratoire de Biologie Moléculaire Hôpital de la Conception, CHU Marseille
• Réseau PREDIR Maladie de VHL et prédispositions héréditaires au cancer du rein, Coordonateur Pr Stéphane RICHARD
• Centre de référence maladies rares hypophysaires  DEFHY Pr T. BRUE, Service d'endocrinologie CHU Timone, Marseille.
• Réseau national de Prise en Charge des Tumeurs (neuro)-Endocrines Malignes rares sporadiques et héréditaires (RENATEN) Pr NICCOLI
• Centre de Compétence "maladies rares des surcharges en Fer" Pr D. BOTTA-FRIDLUND, Service d'Hépatologie hôp. Conception Marseille.

Projets de recherche et contrats avec l’industrie pharmaceutique :

Publications :

2017 (en cours) :

• Brue T, Saveanu A, Jullien N, Fauquier T, Castinetti F, Enjalbert A, Barlier A, Reynaud R. Lessons from monogenic causes of growth hormone deficiency. Ann Endocrinol (Paris). 2017 May 5. pii: S0003-4266(17)30025-2. doi: 10.1016/j.ando.2017.04.001. [Epub ahead of print] PubMed PMID: 28483366.  
• Abdullah AE, Guerin C, Imperiale A, Barlier A, Battini S, Pertuit M, Roche P, Essamet W, Vaisse B, Pacak K, Sebag F, Taïeb D. Paraganglioma of the organ of Zuckerkandl associated with a somatic HIF2α mutation: A case report. Oncol Lett. 2017 Mar;13(3):1083-1086. doi: 10.3892/ol.2017.5599. Epub 2017 Jan 12. PubMed PMID: 28454217; PubMed Central PMCID: PMC5403169.
• Mohamed A, Romano D, Saveanu A, Roche C, Albertelli M, Barbieri F, Brue T, Niccoli P, Delpero JR, Garcia S, Ferone D, Florio T, Moutardier V, Poizat F, Barlier A, Gerard C. Anti-proliferative and anti-secretory effects of everolimus on human pancreatic neuroendocrine tumors primary cultures: is there any benefit from combination with somatostatin analogs? Oncotarget. 2017 Apr 10. doi: 10.18632/oncotarget.17008. [Epub ahead of print] PubMed PMID: 28454119.
• Maignan A, Guerin C, Julliard V, Paladino NC, Kim E, Roche P, Castinetti F, Essamet W, Mancini J, Imperiale A, Clifton-Bligh R, Romanet P, Barlier A, Pacak K, Sebag F, Taïeb D. Implications of SDHB genetic testing in patients with sporadic pheochromocytoma. Langenbecks Arch Surg. 2017 Feb 22. doi: 10.1007/s00423-017-1564-y. [Epub ahead of print] PubMed PMID: 28229225.
• Kern B, Coppin L, Romanet P, Crépin M, Szuster I, Renaud F, Leteurtre E, Frénois F, Wemeau JL, Carnaille B, Cardot-Bauters C, Cao CD, Pigny P. Multiple HABP2 variants in familial papillary thyroid carcinoma: Contribution of a group of "thyroid-checked" controls. Eur J Med Genet. 2017 Mar;60(3):178-184. doi: 10.1016/j.ejmg.2017.01.001. Epub 2017 Jan 9. PubMed PMID: 28089742.
•  

2016 :

• Graillon T, Romano D, Defilles C, Saveanu A, Mohamed A, Figarella-Branger D, Roche PH, Fuentes S, Chinot O, Dufour H, Barlier A. Octreotide therapy in meningiomas: in vitro study, clinical correlation, and literature review. J Neurosurg. 2016 Dec 16:1-10. doi: 10.3171/2016.8.JNS16995. [Epub ahead of print] PubMed PMID: 27982767.
• Chen S, Cavazza E, Barlier C, Salleron J, Filhine-Tresarrieu P, Gavoilles C, Merlin JL, Harlé A. Beside P53 and PTEN: Identification of molecular alterations of the RAS/MAPK and PI3K/AKT signaling pathways in high-grade serous ovarian carcinomas to determine potential novel therapeutic targets. Oncol Lett. 2016 Nov;12(5):3264-3272. Epub 2016 Sep 2. PubMed PMID: 27899992; PubMed Central PMCID: PMC5103928.
• Romanet P, Guerin C, Pedini P, Essamet W, Castinetti F, Sebag F, Roche P, Cascon A, Tischler AS, Pacak K, Barlier A, Taïeb D. Pathological and Genetic Characterization of Bilateral Adrenomedullary Hyperplasia in a Patient with Germline MAX Mutation. Endocr Pathol. 2016 Nov 12. [Epub ahead of print] PubMed PMID: 27838885.
• Thiele S, Mantovani G, Barlier A, Boldrin V, Bordogna P, De Sanctis L, Elli FM, Freson K, Garin I, Grybek V, Hanna P, Izzi B, Hiort O, Lecumberri B, Pereda A, Saraff V, Silve C, Turan S, Usardi A, Werner R, de Nanclares GP, Linglart A. From pseudohypoparathyroidism to inactivating PTH/PTHrP signalling disorder (iPPSD), a novel classification proposed by the EuroPHP network. Eur J Endocrinol. 2016 Dec;175(6):P1-P17. Epub 2016 Jul 11. Review. PubMed PMID: 27401862.
• 9uny T, Zeiller C, Bidlingmaier M, Défilles C, Roche C, Blanchard MP, Theodoropoulou M, Graillon T, Pertuit M, Figarella-Branger D, Enjalbert A, Brue T, Barlier A. In vitro impact of pegvisomant on growth hormone-secreting pituitary adenoma cells. Endocr Relat Cancer. 2016 Jul;23(7):509-19. doi: 10.1530/ERC-16-0140. Epub 2016 Jun 7. PubMed PMID: 27267119; PubMed Central PMCID: PMC5064756.
• Rossignol L, Vaux S, Maugat S, Blake A, Barlier R, Heym B, Le Strat Y, Blanchon T, Hanslik T, Coignard B. Incidence of urinary tract infections and antibiotic resistance in the outpatient setting: a cross-sectional study. Infection. 2017 Feb;45(1):33-40. doi: 10.1007/s15010-016-0910-2. Epub 2016 May 27. PubMed PMID: 27234045.
• Daly AF, Yuan B, Fina F, Caberg JH, Trivellin G, Rostomyan L, de Herder WW, Naves LA, Metzger D, Cuny T, Rabl W, Shah N, Jaffrain-Rea ML, Zatelli MC, Faucz FR, Castermans E, Nanni-Metellus I, Lodish M, Muhammad A, Palmeira L, Potorac I, Mantovani G, Neggers SJ, Klein M, Barlier A, Liu P, Ouafik L, Bours V, Lupski JR, Stratakis CA, Beckers A. Somatic mosaicism underlies X-linked acrogigantism syndrome in sporadic male subjects. Endocr Relat Cancer. 2016 Apr;23(4):221-33. doi: 10.1530/ERC-16-0082. Epub 2016 Mar 2. PubMed PMID: 26935837; PubMed Central PMCID: PMC4877443.
• Vujovic S, Vujosevic S, Kavaric S, Sopta J, Ivovic M, Saveanu A, Brue T, Korbonits M, Popovic V. Cancerous leptomeningitis and familial congenital hypopituitarism. Endocrine. 2016 May;52(2):231-5. doi: 10.1007/s12020-016-0868-y. Epub 2016 Feb 17. PubMed PMID: 26886902.
• Castinetti F, Daly AF, Stratakis CA, Caberg JH, Castermans E, Trivellin G, Rostomyan L, Saveanu A, Jullien N, Reynaud R, Barlier A, Bours V, Brue T, Beckers A. GPR101 Mutations are not a Frequent Cause of Congenital Isolated Growth Hormone Deficiency. Horm Metab Res. 2016 Jun;48(6):389-93. doi: 10.1055/s-0042-100733. Epub 2016 Jan 21. PubMed PMID: 26797872.
• Castinetti F, Reynaud R, Saveanu A, Jullien N, Quentien MH, Rochette C, Barlier A, Enjalbert A, Brue T. MECHANISMS IN ENDOCRINOLOGY: An update in the genetic aetiologies of combined pituitary hormone deficiency. Eur J Endocrinol. 2016 Jun;174(6):R239-47. doi: 10.1530/EJE-15-1095. Epub 2016 Jan 5. Review. PubMed PMID: 26733480.
• Chauvet N, Romanò N, Meunier AC, Galibert E, Fontanaud P, Mathieu MN, Osterstock G, Osterstock P, Baccino E, Rigau V, Loiseau H, Bouillot-Eimer S, Barlier A, Mollard P, Coutry N. Combining Cadherin Expression with Molecular Markers Discriminates Invasiveness in Growth Hormone and Prolactin Pituitary Adenomas. J Neuroendocrinol. 2016 Feb;28(2):12352. doi: 10.1111/jne.12352. PubMed PMID: 26686489.

2015 :

• Daly AF, Lysy PA, Desfilles C, Rostomyan L, Mohamed A, Caberg JH, Raverot V, Castermans E, Marbaix E, Maiter D, Brunelle C, Trivellin G, Stratakis CA, Bours V, Raftopoulos C, Beauloye V, Barlier A, Beckers A. GHRH excess and blockade in X-LAG syndrome. Endocr Relat Cancer. 2016 Mar;23(3):161-70. doi: 10.1530/ERC-15-0478. Epub 2015 Dec 15. PubMed PMID: 26671997. 
• Archier A, Varoquaux A, Garrigue P, Montava M, Guerin C, Gabriel S, Beschmout E, Morange I, Fakhry N, Castinetti F, Sebag F, Barlier A, Loundou A, Guillet B, Pacak K, Taïeb D. Prospective comparison of (68)Ga-DOTATATE and (18)F-FDOPA PET/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases. Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1248-57. doi: 10.1007/s00259-015-3268-2. Epub 2015 Dec 5. PubMed PMID: 26637204.
•  Taïeb D, Barlier A, Yang C, Pertuit M, Tchoghandjian A, Rochette C, Zattara-Canoni H, Figarella-Branger D, Zhuang Z, Pacak K, Metellus P. Somatic gain-of-function HIF2A mutations in sporadic central nervous system hemangioblastomas. J Neurooncol. 2016 Feb;126(3):473-81. doi: 10.1007/s11060-015-1983-y. Epub 2015 Oct 29. PubMed PMID: 26514359. 
• Nielsen HM, How-Kit A, Guerin C, Castinetti F, Vollan HK, De Micco C, Daunay A, Taieb D, Van Loo P, Besse C, Kristensen VN, Hansen LL, Barlier A, Sebag F, Tost J. Copy number variations alter methylation and parallel IGF2 overexpression in adrenal tumors. Endocr Relat Cancer. 2015 Dec;22(6):953-67. doi: 10.1530/ERC-15-0086. Epub 2015 Sep 23. PubMed PMID: 26400872; PubMed Central PMCID: PMC4621769.
• Thevenon J, Bourredjem A, Faivre L, Cardot-Bauters C, Calender A, Le Bras M, Giraud S, Niccoli P, Odou MF, Borson-Chazot F, Barlier A, Lombard-Bohas C, Clauser E, Tabarin A, Pasmant E, Chabre O, Castermans E, Ruszniewski P, Bertherat J, Delemer B, Christin-Maitre S, Beckers A, Guilhem I, Rohmer V, Goichot B, Caron P, Baudin E, Chanson P, Groussin L, Du Boullay H, Weryha G, Lecomte P, Schillo F, Bihan H, Archambeaud F, Kerlan V, Bourcigaux N, Kuhn JM, Vergès B, Rodier M, Renard M, Sadoul JL, Binquet C, Goudet P. Unraveling the intrafamilial correlations and heritability of tumor types in MEN1: a Groupe d'étude des Tumeurs Endocrines study. Eur J Endocrinol. 2015 Dec;173(6):819-26. doi: 10.1530/EJE-15-0691. Epub 2015 Sep 21. PubMed PMID: 26392472.
• Rostomyan L, Daly AF, Petrossians P, Nachev E, Lila AR, Lecoq AL, Lecumberri B, Trivellin G, Salvatori R, Moraitis AG, Holdaway I, Kranenburg-van Klaveren DJ, Chiara Zatelli M, Palacios N, Nozieres C, Zacharin M, Ebeling T, Ojaniemi M, Rozhinskaya L, Verrua E, Jaffrain-Rea ML, Filipponi S, Gusakova D, Pronin V, Bertherat J, Belaya Z, Ilovayskaya I, Sahnoun-Fathallah M, Sievers C, Stalla GK, Castermans E, Caberg JH, Sorkina E, Auriemma RS, Mittal S, Kareva M, Lysy PA, Emy P, De Menis E, Choong CS, Mantovani G, Bours V, De Herder W, Brue T, Barlier A, Neggers SJ, Zacharieva S, Chanson P, Shah NS, Stratakis CA, Naves LA, Beckers A.
• Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients. Endocr Relat Cancer. 2015 Oct;22(5):745-57. doi: 10.1530/ERC-15-0320. Epub 2015 Jul 17. PubMed PMID: 26187128.
• Chanson P, Raverot G, Castinetti F, Cortet-Rudelli C, Galland F, Salenave S; French Endocrinology Society non-functioning pituitary adenoma work-group.. Management of clinically non-functioning pituitary adenoma. Ann Endocrinol (Paris). 2015 Jul;76(3):239-47. doi: 10.1016/j.ando.2015.04.002. Epub 2015 Jun 10. Review. PubMed PMID: 26072284.
• Graillon T, Defilles C, Mohamed A, Lisbonis C, Germanetti AL, Chinot O, Figarella-Branger D, Roche PH, Adetchessi T, Fuentes S, Metellus P, Dufour H, Enjalbert A, Barlier A. Combined treatment by octreotide and everolimus: Octreotide enhances inhibitory effect of everolimus in aggressive meningiomas. J Neurooncol. 2015 Aug;124(1):33-43. doi: 10.1007/s11060-015-1812-3. Epub 2015 May 27. PubMed PMID: 26015296.
• Sarfati J, Saveanu A, Young J. Pituitary stalk interruption and olfactory bulbs aplasia/hypoplasia in a man with Kallmann syndrome and reversible gonadotrope and somatotrope deficiencies. Endocrine. 2015 Aug;49(3):865-6. doi: 10.1007/s12020-014-0475-8. Epub 2014 Nov 9. PubMed PMID: 25381604
• Rochette C, Jullien N, Saveanu A, Caldagues E, Bergada I, Braslavsky D, Pfeifer M, Reynaud R, Herman JP, Barlier A, Brue T, Enjalbert A, Castinetti F. Identifying the Deleterious Effect of Rare LHX4 Allelic Variants, a Challenging Issue. PLoS One. 2015 May 8;10(5):e0126648. doi: 10.1371/journal.pone.0126648. eCollection 2015. PubMed PMID: 25955177; PubMed Central PMCID: PMC4425544.
• Jullien N, Roche C, Brue T, Figarella-Branger D, Graillon T, Barlier A, Herman JP. Dose-dependent dual role of PIT-1 (POU1F1) in somatolactotroph cell proliferation and apoptosis. PLoS One. 2015 Mar 30;10(3):e0120010. doi: 10.1371/journal.pone.0120010. eCollection 2015. PubMed PMID: 25822178; PubMed Central PMCID: PMC4379079.
• Romanet P, Osei L, Netchine I, Pertuit M, Enjalbert A, Reynaud R, Barlier A. Case report of GNAS epigenetic defect revealed by a congenital hypothyroidism. Pediatrics. 2015 Apr;135(4):e1079-83. doi: 10.1542/peds.2014-2806. PubMed PMID: 25802348.
• Garin I, Mantovani G, Aguirre U, Barlier A, Brix B, Elli FM, Freson K, Grybek V, Izzi B, Linglart A, de Nanclares GP, Silve C, Thiele S, Werner R. European guidance for the molecular diagnosis of pseudohypoparathyroidism not caused by point genetic variants at GNAS: an EQA study. Eur J Hum Genet. 2015 Apr;23(4):560. doi: 10.1038/ejhg.2015.40. PubMed PMID: 25762030; PubMed Central PMCID: PMC4666586.
• Imperiale A, Moussallieh FM, Roche P, Battini S, Cicek AE, Sebag F, Brunaud L, Barlier A, Elbayed K, Loundou A, Bachellier P, Goichot B, Stratakis CA, Pacak K, Namer IJ, Taïeb D. Metabolome profiling by HRMAS NMR spectroscopy of pheochromocytomas and paragangliomas detects SDH deficiency: clinical and pathophysiological implications. Neoplasia. 2015 Jan;17(1):55-65. doi: 10.1016/j.neo.2014.10.010. PubMed PMID: 25622899; PubMed Central PMCID: PMC4309730.
• Cuny T, Barlier A, Feelders R, Weryha G, Hofland LJ, Ferone D, Gatto F. Medical therapies in pituitary adenomas: Current rationale for the use and future perspectives. Ann Endocrinol (Paris). 2015 Feb;76(1):43-58. doi: 10.1016/j.ando.2014.10.002. Epub 2014 Nov 11. Review. PubMed PMID: 25556152.
• Dénes J, Swords F, Rattenberry E, Stals K, Owens M, Cranston T, Xekouki P, Moran L, Kumar A, Wassif C, Fersht N, Baldeweg SE, Morris D, Lightman S, Agha A, Rees A, Grieve J, Powell M, Boguszewski CL, Dutta P, Thakker RV, Srirangalingam U, Thompson CJ, Druce M, Higham C, Davis J, Eeles R, Stevenson M, O'Sullivan B, Taniere P, Skordilis K, Gabrovska P, Barlier A, Webb SM, Aulinas A, Drake WM, Bevan JS, Preda C, Dalantaeva N, Ribeiro-Oliveira A Jr, Garcia IT, Yordanova G, Iotova V, Evanson J, Grossman AB, Trouillas J, Ellard S, Stratakis CA, Maher ER, Roncaroli F, Korbonits M. Heterogeneous genetic background of the association of pheochromocytoma/paraganglioma and pituitary adenoma: results from a large patient cohort. J Clin Endocrinol Metab. 2015 Mar;100(3):E531-41. doi: 10.1210/jc.2014-3399. Epub 2014 Dec 12. PubMed PMID: 25494863; PubMed Central PMCID: PMC4333031.
• Trivellin G, Daly AF, Faucz FR, Yuan B, Rostomyan L, Larco DO, Schernthaner-Reiter MH, Szarek E, Leal LF, Caberg JH, Castermans E, Villa C, Dimopoulos A, Chittiboina P, Xekouki P, Shah N, Metzger D, Lysy PA, Ferrante E, Strebkova N, Mazerkina N, Zatelli MC, Lodish M, Horvath A, de Alexandre RB, Manning AD, Levy I, Keil MF, Sierra Mde L, Palmeira L, Coppieters W, Georges M, Naves LA, Jamar M, Bours V, Wu TJ, Choong CS, Bertherat J, Chanson P, Kamenický P, Farrell WE, Barlier A, Quezado M, Bjelobaba I, Stojilkovic SS, Wess J, Costanzi S, Liu P, Lupski JR, Beckers A, Stratakis CA. Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation. N Engl J Med. 2014 Dec 18;371(25):2363-74. doi: 10.1056/NEJMoa1408028. Epub 2014 Dec 3. PubMed PMID: 25470569; PubMed Central PMCID: PMC4291174.

• Urétéroscopie pour calculs et tumeurs du haut appareil
• Cancer du rein
• Cancer de prostate
• Cancer de la vessie
• Transplantation rénale 
• Troubles mictionnels et neuro-urologie

Long-term results of endoscopic treatment in vesicoureteral reflux after kidney transplantation.
Tadrist A, Morelli M, Gondran-Tellier B, Akiki A, McManus R, Delaporte V, Bastide C, Karsenty G, Lechevallier E, Boissier R, Baboudjian M.
World J Urol. 2022 Jan 14. doi: 10.1007/s00345-021-03902-3

HoSAGE: sarcopenia in older patient with intermediate / high-risk prostate cancer, prevalence and incidence after androgen deprivation therapy: study protocol for a cohort trial
Couderc AL, Villani P, Berbis J, Nouguerède E, Rey D, Rossi D, Lechevallier É, Badinand D, Bastide C, Karsenty G, Boissier R, Amichi K, Muracciole X.
BMC Cancer. 2022 Jan 18;22(1):78. doi: 10.1186/s12885-021-09105-8
 
Epidemiology and care pathway of vesicovaginal fistulas managed in France between 2010 and 2018
Michel F, Gaillet S, Boissier R, Delaporte V, Lechevallier E, Bensadoun H, Karsenty G.
World J Urol. 2022 Jan 20. doi: 10.1007/s00345-021-03917-w. 
 
Author Reply to Letter to the Editor
Boissier R, Deledalle FX, Baboudjian M, Lechevallier E.
Urology. 2022 Jan;159:257-258.

Single use and reusable flexible ureteroscopies for the treatment of urinary stones: A comparative study of perioperative complications.
Baboudjian M, Gondran-Tellier B, Abdallah R, Tadrist A, Sichez PC, Akiki A, Gaillet S, Delaporte V, Karsenty G, Lechevallier E, Boissier R.
Prog Urol. 2021 Jan 15:S1166-7087(20)30737-5. doi: 10.1016/j.purol. 2020.11.014

Immediate preoperative renal artery embolization in the resection of complex renal tumors (UroCCR-48 Reinbol study).
Alegorides C, Bigot P, Hardwigsen J, Vidal V, Riberi A, Andre M, Gondran-Tellier B, Baboudjian M, Michel F, Karsenty G, Lechevallier E, Bernhard JC, Boissier R.
Int Urol Nephrol. 2021 Feb;53(2):229-234. doi: 10.1007/s11255-020-02628-2.
 
Efficacy and safety of surgery for benign prostatic obstruction in patients with preoperative urinary catheter.
Gondran-Tellier B, McManus R, Sichez PC, Akiki A, Gaillet S, Toledano H, Andre M, Delaporte V, Vidal V, Karsenty G, Bastide C, Rossi D, Lechevallier E, Boissier R, Baboudjian M.
J Endourol. 2021 Jan;35(1):102-108. doi: 10.1089/end.2020.0704.
 
Miami Pouch: a Simple Technique for Efficient Continent Cutaneous Urinary Diversion
Baboudjian M, Gondran-Tellier B, Michel F, Abdallah R, Rouy M, Gaillet S, Sichez PC, Boissier R, Bladou F, Lechevallier E, Karsenty G.
Urology. 2021 Feb 10:S0090-4295(21)00167-9. doi: 10.1016/j.urology.2021.02.004
 
Intradetrusor injections of botulinum toxin A to treat urinary incontinence due to bladder overactivity during idiopathic Parkinson's disease.
Atamian A, Sichez PC, Michel F, Bandelier Q, Fall M, Gaillet S, Azoulay JP, Lechevallier E, Karsenty G.
Prog Urol. 2021 Feb 9:S1166-7087(21)00005-1. doi: 10.1016/j.purol.2021.01.004
 
Long-term follow-up of renal cell carcinomas T1a treated by percutaneous radiofrequency.
Amadane N, André M, Daniel L, Coulange C, Baboudjian M, Michel F, Gondran-Tellier B, Vanacore D, Lechevallier E, Boissier R.
Prog Urol. 2021 Feb 13:S1166-7087(20)30599-6. doi: 10.1016/j.purol.2020.09.021
 
Micro-percutaneous nephrolithotomy (Microperc) for renal stones, outcomes and learning curve.
Michel F, Negre T, Baboudjian M, Al-Balushi K, Oliva J, Gondran-Tellier B, Sichez PC, Delaporte V, Gaillet S, Aikiki A, Faure A, Karsenty G, Lechevallier E, Boissier R.
Prog Urol. 2021 Feb;31(2):91-98. doi: 10.1016/j.purol.2020.03.006.
  
Continuous saline bladder irrigation after blue light transurethral resection of bladder tumor increases recurrence-free survival in low- to intermediate-risk non-muscle invasive bladder cancer.
Gondran-Tellier B, Abdallah R, Sichez PC, Akiki A, Toledano H, Gaillet S, Delaporte V, Karsenty G, Bastide C, Daniel L, Garcia S, Rossi D, Lechevallier E, Boissier R, Baboudjian M .
Prog Urol. 2021 Mar 1:S1166-7087(21)00028-2. doi: 10.1016/j.purol.2021.01.011
 
Primary Complete Transurethral Resection of Bladder Tumor using Photodynamic Diagnosis for High-risk Non-Muscle Invasive Bladder Cancer: Is a Restaging Photodynamic Transurethral Resection Really Necessary?
Tadrist A, Gondran-Tellier B, McManus R, Al-Balushi K, Akiki A, Gaillet S, Delaporte V, Karsenty G, Lechavallier E, Boissier R, Baboudjian M.
J Endourol. 2021 Feb 25. doi: 10.1089/end.2020.1107
 
Povidone-iodine sclerotherapy of primary symptomatic lymphocele after kidney transplantation
Baboudjian M, Tadrist A, Gondran-Tellier B, McManus R, Akiki A, Gaillet S, Delaporte V, Carballeira A, Andre M, Karsenty G, Lechevallier E, Boissier R.
Int Urol Nephrol. 2021 Apr;53(4):685-690. doi: 10.1007/s11255-020-02709-2
 
Is minor surgery safe during the COVID-19 pandemic? A multi-disciplinary study
Baboudjian M, Mhatli M, Bourouina A, Gondran-Tellier B, Anastay V, Perez L, Proye P, Lavieille JP, Duchateau F, Agostini A, Wazne Y, Sebag F, Foletti JM, Chossegros C, Raoult D, Touati J, Chagnaud C, Michel J, Bertrand B, Giovanni A, Radulesco T, Sartor C, Fournier PE, Lechevallier E.
PLoS One. 2021 May 11;16(5):e0251122. doi: 10.1371/journal.
 
Active surveillance for biopsy proven renal oncocytomas: outcomes and feasibility
Deledalle FX, Ambrosetti D, Durand M, Michel F, Baboudjian M, Gondran-Tellier B, Lannes F, Daniel L, André M, Fais PO, Savoie PH, Durand X, Rossi D, Karsenty G, Bastide C, Lechevallier E, Boissier R.
Urology. 2021 Jun 1:S0090-4295(21)00453-2. doi: 10.1016/j. urology.2021.05.034. 
 
Comparison of water vapor thermal therapy and prostate artery embolization for fragile patients with indwelling urinary catheters: Preliminary results from a multi-institutional study.
Baboudjian M, Alegorides C, Fourmarier M, Atamian A, Gondran-Tellier B, Andre M, Arroua F, Boissier R, Eghazarian C, Vidal V, Chevrot A, Droupy S, Lechevallier E.
Prog Urol. 2021 Jun 17:S1166-7087(21)00066-X. doi: 10.1016/j. purol.2021.03.001.
 
Évaluation médico-economique de l’impact de mesures d’adaptation au virage de la chirurgie robot-assistée en urologie
Durand M, Bentellis I, Shaikh A, Barthe F, Imbert de la Phalecque L, Tibi B, Ahallal Y, Elleboode B, Guepratte C, Acloque D, Lechevallier E, Chevallier D.
Prog Urol. 2021 Jun 18:S1166-7087(21)00065-8. doi: 10.1016/j.purol.2020.12.019
 
Sunitinib Alone or After Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Is There Still a Role for Cytoreductive Nephrectomy?
Méjean A, Ravaud A, Thezenas S, Chevreau C, Bensalah K, Geoffrois L, Thiery-Vuillemin A, Cormier L, Lang H, Guy L, Gravis G, Rolland F, Linassier C, Lechevallier E, Oudard S, Laguerre B, Gross-Goupil M, Bernhard JC, Colas S, Albiges L, Lebret T, Treluyer JM, Timsit MO, Escudier B.
Eur Urol. 2021 Jun 26:S0302-2838(21)01815-7. doi: 10.1016/j.eururo.2021.06.009
 
Stereotactic Body Radiotherapy for Frail Patients with Primary Renal Cell Carcinoma: Preliminary Results after 4 Years of Experience
Grelier L, Baboudjian M, Gondran-Tellier B, Couderc AL, McManus R, Deville JL, Carballeira A, Delonca R, Delaporte V, Padovani L, Boissier R, Lechevallier E, Muracciole X.
Cancers (Basel). 2021 Jun 23;13(13):3129. doi: 10.3390/cancers13133129
 
Early PDD Cystoscopy after BCG Induction for High-risk Non-Muscle Invasive Bladder Cancer Significantly Increased the Detection of BCG-refractory Tumors
Morelli M, Baboudjian M, Vanacore D, Gondran-Tellier B, McManus R, Karsenty G, Lechavallier E, Montanari E, Boissier R.
J Endourol. 2021 Jun 9. doi: 10.1089/end.2021.0313. 
 
Response to Editorial Comment: "Primary Complete Transurethral Resection of Bladder Tumor Using Photodynamic Diagnosis for High-risk Nonmuscle Invasive Bladder Cancer: Is a Restaging Photodynamic Transurethral Resection Really Necessary?"
Baboudjian M, Tadrist A, Lechevallier E.
J Endourol. 2021 Jul;35(7):1049-1050. doi: 10.1089/end.2021.29113.mb
 
Ureteral reimplantation after deflux failure for vesicoureteral reflux in renal transplant
Morelli M, Boissier R, Tadrist A, Gondran-Tellier B, McManus R, Akiki A, Delaporte V, Karsenty G, Concetti S, Montanari E, Lechevallier E, Baboudjian M.
World J Urol. 2021 Aug 20. doi: 10.1007/s00345-021-03814-2
 
Single-use versus reusable flexible ureteroscope: Technical and medico-economic aspects
Carlier M, Baboudjian M, Govidin L, Yahia M, Chiappini J, Lechevallier E, Boissier R.
Prog Urol. 2021 Aug 26:S1166-7087(21)00218-9. doi: 10.1016/j.purol.2021.08.040. 
 
Preoperative polymicrobial urine culture: An analysis of the risk of perioperative urinary tract infection
Breuleux C, Gondran-Tellier B, Guerin V, McManus R, Pauly V, Lechevallier E, Albanese J, Baboudjian M.
Prog Urol. 2021 Sep 30:S1166-7087(21)00450-4. doi: 10.1016/j.purol.2021.09.002
 
Efficacy of HIVEC in patients with high-risk non-muscle invasive bladder cancer who are contraindicated to BCG and in patients who fail BCG therapy.
Doisy L, A. Cimier, A. Adypagavane, J. Walz, T.Marquette, T. Maubon, S. Rybikowski, S. Fakhfakh, K. Loverde, N. Mottet, J. Irani, E. Lechevallier, D. Rossi, G. Gravis,G.Pignot
Int J Hyperthermia 2021, 38 :1633-1638
 
Reply to Kokayi A, Warren H, Tranb M s' Letter to the Editor-Active Surveillance for Biopsy Proven Renal Oncocytomas: Outcomes and Feasibility. Urology 2021. doi: 10.1016/j.urology.2021.05.034. Online Ahead of Print
Boissier R, Deledalle FX, Baboudjian M, Lechevallier E.
Urology. 2021 Oct 30:S0090-4295(21)00930-4. doi: 10.1016/j.urology.2021.10.014
Pedagogical impact of a MOOC on surgical technique of kidney transplantation Prudhomme T, Karam G, Roumiguié M, Bardet F, Sallusto F, Soulié M, Gamé X, Kamar N, Phé V, Pradère B, Blancho G, Lechevallier É, Branchereau J.
Prog Urol. 2021 Dec 14:S1166-7087(21)00566-2. doi: 10.1016/j.purol.2021.11.001
 
Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration resistant prostate cancer: The CATS international database.
Delanoy N, Hardy-Bessard AC, Efstathiou E, Le Moulec S, Basso U, Birtle A, Thomson A, Krainer M, Guillot A, De Giorgi U, Hasbini A, Daugaard G, Bahl A, Chowdhury S, Caffo O, Beuzeboc P, Spaeth D, Eymard JC, Fléchon A, Alexandre J, Helissey C, Butt M, Priou F, Lechevallier E, Deville JL, Gross-Goupil M, Morales R, Thiery-Vuillemin A, Gavrikova T, Barthélémy P, Sella A, Fizazi K, Ferrero JM, Laguerre B, Thibault C, Hans S, Oudard S.
Eur J Cancer. 2020,125:153-163
 
Diagnostic ureteroscopy prior to nephroureterectomy for urothelial carcinoma is associated with a high risk of bladder recurrence despite technical precautions to avoid tumor spillage.
Baboudjian M, Al-Balushi K, Michel F, Lannes F, Akiki A, Gaillet S, Delaporte V, Ragni E, Toledano H, Karsenty G, Rossi D, Bastide C, Lechevallier E, Boissier R.
World J Urol. 2020 ,38:159-165
 
Pelvic Surgery in the Transplant Recipient: Important Considerations for the Non-transplant Surgeon.
Boissier R, Delaporte V, Legris T, Moal V, Lechevallier E.
Curr Urol Rep. 2020, 18;21(1):2.
 
HoSAGE: Sarcopenia in Older Patients before and after Treatment with Androgen Deprivation Therapy and Radiotherapy for Prostate Cancer.
Couderc AL, Muracciole X, Nouguerede E, Rey D, Schneider S, Champsaur P, Lechevallier E, Lalys L, Villani P.
J Nutr Health Aging. 2020,24:205-209.
 
Perirenal adipose tissue displays an age-dependent inflammatory signature associated with early graft dysfunction of marginal Kkdney transplants
R. Boissier, P. François, B. Gondran Tellier, M. Meunier, L. Lyonnet, S. Simoncini, J. Magalon, T. Legris, L. Arnaud, L. Giraudo5, F. Dignat George, G. Karsenty, S. Burtey, E. Lechevallier, F. Sabatier, P. Paul
Frontiers in Immunology 2020, 11 : 445. doi: 10.3389/fimmu.2020.00445
 
Selective trans-arterial embolization of iatrogenic vascular lesions did not influence the global renal function after partial nephrectomy.
Baboudjian M, Gondran-Tellier B, Abdallah R, Lannes F, Sichez PC, Akiki A, Gaillet S, Toledano H, Delaporte V, Andre M, Karsenty G, Lechevallier E, Rossi D, Vidal V, Boissier R, Bastide C.
Urology. 2020 Apr 10. pii: S0090-4295(20)30360-5. doi: 10.1016/j.urology.2020.03.036
 
Evolution of followed renal oncocytomas
Deledalle FX, Doisy L, Daniel L, Garcia S, Lechevallier E, Bastide C, Boissier R.
Prog Urol. 2020 May 3. pii: S1166-7087(20)30110-X. doi: 10.1016/j.purol.2020.04.006

Micro-percutaneous nephrolithotomy (Microperc) for renal stones, outcomes and learning curve.
Michel F, Negre T, Baboudjian M, Al-Balushi K, Oliva J, Gondran-Tellier B, Sichez PC, Delaporte V, Gaillet S, Aikiki A, Faure A, Karsenty G, Lechevallier E, Boissier R.
Prog Urol. 2020 May 3. pii: S1166-7087(20)30098-1. doi: 10.1016/j.purol.2020.03.006.
 
The prognostic value of serum procalcitonin in acute obstructive pyelonephritis
Baboudjian M, Gondran-Tellier B, Di Bisceglie M, Abdallah R, Michel F, Sichez PC, Al-Balushi K, Akiki A, Gaillet S, Delaporte V, Karsenty G, Lechevallier E, Guieu R, Boissier R
World J Urol. 2020 Jul 15. doi: 10.1007/s00345-020-03353-2
 
Immediate preoperative renal artery embolization in the resection of complex renal tumors (UroCCR-48 Reinbol study).
Alegorides C, Bigot P, Hardwigsen J, Vidal V, Riberi A, Andre M, Gondran-Tellier B, Baboudjian M, Michel F, Karsenty G, Lechevallier E, Bernhard JC, Boissier R.
Int Urol Nephrol. 2020 Sep 2. doi: 10.1007/s11255-020-02628-2.
 
Nonsuspicious prebiopsy multiparametric MRI: is prostate biopsy still necessary?
Anastay V, Gondran-Tellier B, McManus R, Delonca R, Akiki A, Gaillet S, Delaporte V, Andre M, Daniel L, Karsenty G, Lechevallier E, Boissier R, Baboudjian M.
Abdom Radiol (NY). 2020 Sep 9. doi: 10.1007/s00261-020-02728-8
 
Efficacy and Safety of Surgery for Benign Prostatic Obstruction in Patients with Preoperative Urinary Catheter
Gondran-Tellier B, McManus R, Sichez PC, Akiki A, Gaillet S, Toledano H, Andre M, Delaporte V, Vidal V, Karsenty G, Bastide C, Rossi D, Lechevallier E, Boissier R, Baboudjian M.
J Endourol. 2020 Sep 23. doi: 10.1089/end.2020.0704
 
Transplantation rénale: pour qui, pourquoi et comment.
Gondran-Tellier B, Baboudjian M, Lechevallier E, Boissier R.
Prog Urol. 2020 Oct 11:S1166-7087
 
Facteurs de risque de récidive et de progression après traitement par HIVEC.
Doisy L, Cimier A, Adypagavane A, Walz J, Marquette T, Maubon T, Rybikowski
S, Fakhfakh S, Loverde K, Mottet N, Irani J, Lechevallier E, Rossi D, Gravis G,
Pignot G.

Intérêt d’une cystoscopie Hexvix de clôture après BCG d’induction pour TVNIM à haut risque de récidive et de progression.
Baboudjian M, Vanacore D, Gondran-Tellier B, Karsenty G, Boissier R,
Lechevallier E.
Prog Urol.2020 Nov;30(13):832.

 Intérêt d’un second look en lumière bleue après une primo- résection transurétrale de vessie en lumière bleue macroscopiquement complète.
Tadrist A, Baboudjian M, Gondran-Tellier B, Boissier R, Karsenty G,
Lechevallier E.
Prog Urol. 2020 Nov;30(13):831-832.

Étude multicentrique et rétrospective évaluant l’impact des différentes modalités de traitement antibiotique d’une colonisation urinaire avant chirurgie urologique.
Kutchukian S, Baboudjian M, Robin H, Lechevallier E, Gondran-Tellier B,Vallée M.
Prog Urol. 2020 Nov;30(13):793-794.

Efficacité et sécurité de la chirurgie de désobstruction prostatique après une rétention aiguë d’urines en échec de désondage.
Baboudjian M, Gondran-Tellier B, Boissier R, Vidal V, Karsenty G, Lechevallier E.
Prog Urol. 2020 Nov;30(13):768-769.

Fistules uro-génitales féminines dans un CHU français durant la dernière décennie : description et résultats de la prise en charge.
Michel F, Gaillet S, Boissier R, Delaporte V, Ragni-Ghazarossian E, Bastide C, Rossi D, Lechevallier E, Karsenty G.
Prog Urol. 2020 Nov;30(13):761.

Épidémiologie et parcours de soin des fistules vésicovaginales opérées en France en 2017 à partir de l’analyse du PMSI.
Michel F, Bensadoun H, Gaillet S, Boissier R, Delaporte V, Lechevallier E,
Karsenty G.Prog Urol. 2020 Nov;30(13):760-761.

Résultats des ballons péri-urétraux ajustables (ACT) dans le traitement de l’incontinence urinaire d’effort complexe de la femme adulte.
Bandelier Q, Michel F, Boissier R, Gaillet S, Delaporte V, Fasnewindé Kaboré A, Lechevallier E, Karsenty G.
Prog Urol. 2020 Nov;30(13):752-753.

IRM multiparamétrique systématique non suspecte avant biopsie : la biopsie de prostate est-elle toujours indiquée ?
Anastay V, Baboudjian M, Gondran-Tellier B, Karsenty G, Boissier R,
Lechevallier E.
Prog Urol. 2020 Nov;30(13):740.
 
Povidone-iodine sclerotherapy of primary symptomatic lymphocele after kidney transplantation
Baboudjian M, Tadrist A, Gondran-Tellier B, McManus R, Akiki A, Gaillet S, Delaporte V, Carballeira A, Andre M, Karsenty G, Lechevallier E, BoissierInt
Urol Nephrol. 2020 Nov 10. doi: 10.1007/s11255-020-02709-2

 Deciphering the urinary microbiota repertoire by culturomics reveals mostly anaerobic bacteria from the gut.
Dubourg G, Morand A, Mekhalif F, Godefroy R,  Corthier A, Yacouba A, Diakite A, Cornu F, Cresci M, Brahimi S, CaputoA, Lechevallier E, Tsimaratos M, Moal V, LagieR JC, Raoult D
Frontiers in Microbiology 2020 Oct, 11. article 513305

Impact of Androgen Deprivation Therapy Associated to Conformal Radiotherapy in the Treatment of D'Amico Intermediate-/High-Risk Prostate Cancer in Older Patients.
Couderc AL, Nicolas E, Boissier R, Boucekine M, Bastide C, Badinand D, Rossi D, Mugnier B, Villani P, Karsenty G, Cowen D, Lechevallier E, Muracciole X.
Cancers 2020 Dec 29;13(1):E75